Skip to main content
TipRanks
Go Ultimate75% OFF

First Tracks Biotherapeutics Inc (TRAX) Income Statement

57 Followers

First Tracks Biotherapeutics Inc Income Statement

Last quarter (Q3 2026), First Tracks Biotherapeutics Inc's total revenue was $0.00. In Q3, First Tracks Biotherapeutics Inc's net income was $-31.36M. See First Tracks Biotherapeutics Inc’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23
$ 0.00$ 0.00$ 0.00
$ -139.61M$ -152.34M$ 0.00
$ 39.39M$ 28.76M$ 118.46M
Depreciation and Amortization$ 2.42M$ 2.40M$ 2.38M
$ -176.58M$ -178.70M$ -116.08M
$ -179.01M$ -181.10M$ -118.46M
$ 12.92M$ 17.40M$ 12.31M
$ -166.09M$ -163.71M$ -106.15M
$ -166.09M$ -163.71M$ -106.15M
Per Share Metrics
Basic EPS$ 0.00$ 0.00$ -3.05
Diluted EPS$ 0.00$ 0.00$ -3.05
Weighted Average Shares Outstanding34.75M34.75M34.75M
Weighted Average Shares Outstanding (Diluted)34.75M34.75M34.75M

Currency in USD

First Tracks Biotherapeutics Inc Earnings and Revenue History

-180M-120M-60M00 %0.4 %0.8 %1.2 %EarningsProfit Margin202320242025RevenueEarningsProfit Margin